Spots Global Cancer Trial Database for Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
Official Title: A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian
Study ID: NCT01538498
Conditions
Interventions
Study Description
Brief Summary: * Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively * Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics
Detailed Description: Patients with primary ovarian cancer * Informed consent * Digital photography \& Checking PCI (tumor size, number, and Characteristics) * Postoperative surveillance(tumor marker, image and physical examination) 1. Developing the best fitting PCI model to reflect recurrence-free survival and overall survival * Selection of items * Weighting by items and tumor characteristics 2. Analysis of prognostic impact of PCI compared to conventional staging system (FIGO stage) for ovarian cancer
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
National Cancer Center, Goyang-si, Gyeonggi-do, Korea, Republic of
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
